Cancer BiologyEndocrinologyPeer-reviewed
ESR1 fusion proteins invoke breast cancer subtype-dependent enrichment of ligand independent pro-oncogenic signatures and phenotypes
Megan E. Yates, Hunter Waltermire, Kanako Mori…·Steffi Oesterreich
This study shows ER fusion proteins in breast cancer cell lines drive ligand-independent pro-oncogenic pathways, with subtype- and fusion-specific effects.
11 citations